Medicare Enrolled
Dr. Timur Pogodin, M.D
Dermatology · Los Angeles, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Pogodin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pogodin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Pogodin
Dr. Timur Pogodin is a dermatology specialist in Los Angeles, CA, with 11 years of NPI registration. Based on federal Medicare data, Dr. Pogodin performed 1,409 Medicare services across 843 unique beneficiaries.
Between the years covered by Open Payments, Dr. Pogodin received a total of $11,167 from 46 pharmaceutical and/or device companies across 427 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Pogodin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 11 years in practice
▲ Top 27% volume in CA
$11,167 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,409
Medicare services
Top 27% in CA for dermatology
843
Unique beneficiaries
$108
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~128 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
687 | $141 | $370 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
144 | $140 | $200 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
97 | $12 | $80 |
| Complex chronic care management, first 60 minutes This service involves clinical staff time directed by a healthcare professional to manage two or more chronic conditions over a calendar month. It covers the first 60 minutes of this coordinated care effort. |
94 | $113 | $250 |
| Additional chronic care management time, 60 minutes This service covers an additional 60 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions, billed per calendar month. |
86 | $59 | $300 |
| Obesity behavioral counseling, 15 minutes A 15-minute face-to-face session focused on behavioral counseling to help manage obesity. |
78 | $27 | $200 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
42 | $52 | $150 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
39 | $41 | $200 |
| Annual depression screening | 34 | $19 | $150 |
| Chronic care management, additional 30 minutes This service covers an extra 30 minutes of care management provided by a healthcare professional for patients with two or more chronic conditions. It is billed per calendar month in addition to the standard chronic care management time. |
26 | $51 | $150 |
| Chronic care management, first 30 minutes This service covers the initial 30 minutes of care coordination for patients with two or more chronic conditions. It is provided personally by a healthcare professional each calendar month. |
26 | $72 | $200 |
| Home visit, established patient, high complexity A home visit for an established patient involving high-level medical decision making, lasting at least 60 minutes. |
22 | $152 | $400 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
17 | $97 | $310 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
17 | $178 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$11,167
Total received (2018-2024)
Avg $1,595/year across 7 years
Top 4% in CA for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
427
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,701 (86.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,466 (13.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,419
2023
$1,827
2022
$2,298
2021
$2,255
2020
$861
2019
$1,073
2018
$434
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$400
GlaxoSmithKline, LLC.
$248
Novo Nordisk Inc
$208
Amgen Inc.
$193
Lilly USA, LLC
$167
Phathom Pharmaceuticals, Inc.
$158
Optinose US, Inc.
$156
Otsuka America Pharmaceutical, Inc.
$121
ABBVIE INC.
$115
Regeneron Healthcare Solutions, Inc.
$101
PFIZER INC.
$92
Dexcom, Inc.
$73
Sage Therapeutics, Inc.
$59
Sumitomo Pharma America, Inc.
$47
Teva Pharmaceuticals USA, Inc.
$44
Phadia US Inc.
$39
Boehringer Ingelheim Pharmaceuticals, Inc.
$32
Bayer Healthcare Pharmaceuticals Inc.
$29
Mylan Specialty L.P.
$26
Exact Sciences Corporation
$24
SHIELD THERAPEUTICS INC
$20
Hologic Sales and Service, LLC
$19
Alnylam Pharmaceuticals Inc.
$18
Xeris Pharmaceuticals, Inc.
$15
Azurity Pharmaceuticals, Inc.
$14
Top 3 companies account for 35.4% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,575
Biohaven Pharmaceuticals, Inc.
$1,466
AstraZeneca Pharmaceuticals LP
$1,416
GlaxoSmithKline, LLC.
$1,176
Amgen Inc.
$847
Boehringer Ingelheim Pharmaceuticals, Inc.
$606
Lilly USA, LLC
$600
PFIZER INC.
$417
ABBVIE INC.
$376
Dexcom, Inc.
$268
Merck Sharp & Dohme Corporation
$231
Merck Sharp & Dohme LLC
$206
Amarin Pharma Inc.
$165
Phathom Pharmaceuticals, Inc.
$158
Optinose US, Inc.
$156
Novartis Pharmaceuticals Corporation
$154
Abbott Laboratories
$139
Otsuka America Pharmaceutical, Inc.
$121
Regeneron Healthcare Solutions, Inc.
$101
Phadia US Inc.
$78
Gilead Sciences, Inc.
$66
AbbVie, Inc.
$62
Sage Therapeutics, Inc.
$59
Teva Pharmaceuticals USA, Inc.
$59
Bayer Healthcare Pharmaceuticals Inc.
$52
AbbVie Inc.
$50
Bayer HealthCare Pharmaceuticals Inc.
$48
Sumitomo Pharma America, Inc.
$47
Mylan Specialty L.P.
$47
Biohaven Pharmaceutical Holding Company Ltd.
$42
SANOFI-AVENTIS U.S. LLC
$42
Sun Pharmaceutical Industries Inc.
$37
Metacel Pharmaceuticals LLC
$37
Xeris Pharmaceuticals, Inc.
$34
Ironwood Pharmaceuticals, Inc
$28
Allergan, Inc.
$27
Exact Sciences Corporation
$24
Hologic, LLC
$21
Alkermes, Inc.
$20
SHIELD THERAPEUTICS INC
$20
Hologic Sales and Service, LLC
$19
Alnylam Pharmaceuticals Inc.
$18
Evoke Pharma, Inc.
$15
Azurity Pharmaceuticals, Inc.
$14
Nevro Corp.
$13
Eisai Inc.
$13
Top 3 companies account for 39.9% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AIRSUPRA · AMVUTTRA · ANORO ELLIPTA · APTIMA · AREXVY · ARISTADA · AUSTEDO · Aimovig · Austedo XR · BELSOMRA · BEVESPI AEROSPHERE · BREZTRI · BYDUREON · CHANTIX · COMIRNATY · CREON · Cologuard Collection Kit · Creon · DRIZALMA SPRINKLE · DUPIXENT · Dayvigo · Descovy · Dexcom G6 Transmitter · EDARBI · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · EZALLOR SPRINKLE · FARXIGA · FREESTYLE LIBRE 2 · GEMTESA · GIMOTI · GVOKE HYPOPEN · ImmunoCAP · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LINZESS · Linzess · MOUNJARO · NURTEC ODT · Omnia · Otezla · Ozempic · Ozobax · Prolia · QULIPTA · REXULTI · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · SYNJARDY · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · UBRELVY · VERQUVO · VIIBRYD · VOQUEZNA · VRAYLAR · Vascepa · Xhance · YUPELRI · ZEPBOUND · ZURZUVAE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (87%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for dermatology in CA.
Geographic Context
Dermatologists within 10 mi
529
Per 100K population
5.4
County median income
$87,760
Nearest hospital
KAISER FOUNDATION HOSPITAL - WEST LA
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Pogodin is a clinical cardiology specialist, with above-average Medicare volume (top 27% in CA), with low-engagement industry engagement in the top 4% of CA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Pogodin experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Pogodin performed 687 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pogodin receive payments from pharmaceutical companies?
Yes. Dr. Pogodin received a total of $11,167 from 46 companies across 427 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pogodin's costs compare to other dermatologists in Los Angeles?
Dr. Pogodin's average Medicare payment per service is $108. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pogodin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Dermatology
Common procedures, typical costs, and what industry payments mean in dermatology.
Same specialty & city
Dermatologists in Los Angeles
Browse dermatologists in Los Angeles ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in CA
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in CA
Which CA dermatologists receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Biohaven Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Biohaven Pharmaceuticals, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology